AAOS Research Symposium Updates and Consensus: Biologic Treatment of Orthopaedic Injuries.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27227987.
- Also identified by DOI 10.5435/JAAOS-D-16-00086 and PMC identifier 6548434.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Strategies that seek to enhance musculoskeletal tissue regeneration and repair by modulating the biologic microenvironment at the site of injury have considerable therapeutic potential. Current and emerging biologic approaches include the use of growth factors, platelet-rich plasma, stem cell therapy, and scaffolds. The American Academy of Orthopaedic Surgeons hosted a research symposium in November 2015 to review the current state-of-the-art biologic treatments of articular cartilage, muscle, tendon, and bone injuries and identify knowledge gaps related to these emerging treatments. This review outlines the findings of the symposium and summarizes the consensus reached on how best to advance research on biologic treatment of orthopaedic injuries.
Medical subject headings
- Biological Products
- Fractures, Bone
- Regeneration
- Tendon Injuries